Changmao Biochemical Engineering Company Limited (HKG:0954)
0.3300
-0.0050 (-1.49%)
Apr 13, 2026, 3:26 PM HKT
HKG:0954 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 68.15 | 57.96 | 89.55 | 59.99 | 58.63 |
Short-Term Investments | 3.65 | 16.6 | 7 | 3.64 | - |
Cash & Short-Term Investments | 71.8 | 74.57 | 96.56 | 63.63 | 58.63 |
Cash Growth | -3.71% | -22.78% | 51.75% | 8.53% | -56.36% |
Accounts Receivable | 75.49 | 63 | 87.94 | 75.42 | 87.84 |
Other Receivables | 13.41 | 11.41 | 13.87 | 42.15 | 27.38 |
Receivables | 88.9 | 74.41 | 101.8 | 117.57 | 115.22 |
Inventory | 110.36 | 143.35 | 132.08 | 160.91 | 122.9 |
Prepaid Expenses | - | 5.35 | 6.27 | - | - |
Restricted Cash | - | 1.11 | 1.61 | 12.34 | 14.75 |
Other Current Assets | - | 0.01 | - | 7.59 | 5.53 |
Total Current Assets | 271.05 | 298.79 | 338.32 | 362.05 | 317.03 |
Property, Plant & Equipment | 886.36 | 924.98 | 865.86 | 773.42 | 597.56 |
Other Intangible Assets | 0.37 | 0.51 | 0.64 | 0.77 | 1.02 |
Long-Term Deferred Tax Assets | - | 0.22 | 0.68 | 24.65 | 20.49 |
Other Long-Term Assets | 21.94 | 25.26 | 37 | 45.86 | 20.42 |
Total Assets | 1,180 | 1,250 | 1,242 | 1,207 | 956.52 |
Accounts Payable | 25.99 | 28.7 | 30.77 | 66.54 | 95.81 |
Accrued Expenses | - | 10.54 | 13.06 | 21.04 | 8.38 |
Short-Term Debt | - | 232.11 | 187.55 | 103.9 | 78.4 |
Current Portion of Long-Term Debt | 427.64 | 282.63 | 54.65 | 33.64 | 8.5 |
Current Portion of Leases | 50.89 | 0.68 | 0.96 | 0.68 | 0.58 |
Current Income Taxes Payable | - | - | - | 3.31 | 6.4 |
Current Unearned Revenue | 42.97 | 7.52 | 5.16 | 6.28 | 8.36 |
Other Current Liabilities | - | 42.38 | 33.09 | 38.63 | 50.3 |
Total Current Liabilities | 547.49 | 604.55 | 325.24 | 274.02 | 256.71 |
Long-Term Debt | 60.32 | 20.3 | 250.41 | 152.07 | 1.5 |
Long-Term Leases | 0.22 | 0.42 | 1.07 | 1.21 | 0.27 |
Long-Term Unearned Revenue | 54.78 | 40.47 | 13.58 | 0.04 | 0.06 |
Long-Term Deferred Tax Liabilities | 0.74 | 0.68 | 0.6 | 0.53 | 0.45 |
Total Liabilities | 663.56 | 666.42 | 590.91 | 427.86 | 258.99 |
Common Stock | 52.97 | 52.97 | 52.97 | 52.97 | 52.97 |
Additional Paid-In Capital | - | 102.56 | 102.56 | 102.56 | 102.56 |
Retained Earnings | - | 426.29 | 494.65 | 622.54 | 541.11 |
Comprehensive Income & Other | 463.71 | 1.63 | 1.51 | 0.47 | 0.46 |
Total Common Equity | 516.68 | 583.45 | 651.69 | 778.53 | 697.1 |
Minority Interest | -0.51 | -0.11 | -0.1 | 0.36 | 0.43 |
Shareholders' Equity | 516.17 | 583.34 | 651.59 | 778.89 | 697.53 |
Total Liabilities & Equity | 1,180 | 1,250 | 1,242 | 1,207 | 956.52 |
Total Debt | 539.07 | 536.13 | 494.65 | 291.5 | 89.26 |
Net Cash (Debt) | -467.27 | -461.57 | -398.09 | -227.87 | -30.63 |
Net Cash Per Share | -0.88 | -0.87 | -0.75 | -0.43 | -0.06 |
Filing Date Shares Outstanding | 529.7 | 529.7 | 529.7 | 529.7 | 529.7 |
Total Common Shares Outstanding | 529.7 | 529.7 | 529.7 | 529.7 | 529.7 |
Working Capital | -276.44 | -305.76 | 13.08 | 88.03 | 60.31 |
Book Value Per Share | 0.98 | 1.10 | 1.23 | 1.47 | 1.32 |
Tangible Book Value | 516.31 | 582.94 | 651.05 | 777.76 | 696.08 |
Tangible Book Value Per Share | 0.97 | 1.10 | 1.23 | 1.47 | 1.31 |
Buildings | - | 401.76 | 289.52 | 273.77 | 210.9 |
Machinery | - | 640.92 | 543.86 | 482.6 | 399.21 |
Construction In Progress | - | 230.34 | 339.05 | 250.54 | 211.16 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.